Titel

Merkliste
1 Ergebnisse

Table1_Benefits and Harms of Low-Dose Rivaroxaban in Asian ..:

Jun Qian (108736) ; Yi-Dan Yan (5370131) ; Sheng-Yan Yang (10888917)...
https://figshare.com/articles/dataset/Table1_Benefits_and_Harms_of_Low-Dose_Rivaroxaban_in_Asian_Patients_With_Atrial_Fibrillation_A_Systematic_Review_and_Meta-analysis_of_Real-World_Studies_docx/14693661. , 2021

Link: https://doi.org/10.3389/fphar.2021.642907.s002

RT Journal
T1 <Title>Table1_Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies.docx</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14693661&Exemplar=1&LAN=DE
				
A1 Jun Qian (108736)
A1 Yi-Dan Yan (5370131)
A1 Sheng-Yan Yang (10888917)
A1 Chi Zhang (9857)
A1 Wen-Yan Li (589195)
A1 Zhi-Chun Gu (5080523)
YR 2021
K1 Pharmacology
K1 Basic Pharmacology
K1 Clinical Pharmacology and Therapeutics
K1 Clinical Pharmacy and Pharmacy Practice
K1 Pharmaceutical Sciences
K1 Pharmacogenomics
K1 Toxicology (incl. Clinical Toxicology)
K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified
K1 atrial fibrillation
K1 direct oral anticoagulants
K1 rivaroxaban
K1 Asian
K1 low-dose
JF https://figshare.com/articles/dataset/Table1_Benefits_and_Harms_of_Low-Dose_Rivaroxaban_in_Asian_Patients_With_Atrial_Fibrillation_A_Systematic_Review_and_Meta-analysis_of_Real-World_Studies_docx/14693661
LK http://dx.doi.org/https://doi.org/10.3389/fphar.2021.642907.s002
DO https://doi.org/10.3389/fphar.2021.642907.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)